Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New injection could rival PRP for shoulder pain relief

NCT ID NCT06160427

Symptom relief Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study compares two types of injections for people with shoulder pain caused by rotator cuff tendinopathy. One injection, CTM Boost, is made from donated placental tissue, and the other, PRP, uses a patient's own blood. The goal is to see if CTM Boost works as well as PRP at reducing pain and improving shoulder function after a single injection. The trial involves 92 adults aged 18 to 80.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Connective Tissue Matrix (CTM) Boost, a biologic derived from placental connective tissue, and Platelet Rich Plasma (PRP), made from the patient's own blood
What this could lead to
If CTM Boost proves as effective as PRP, it could offer another treatment option for people with shoulder pain from rotator cuff tendinopathy.
What could go wrong
This is a relatively small, single-center trial comparing two existing treatments, so results may not apply broadly. There is also a chance CTM Boost is less effective than PRP.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

92 people

The number who actually took part.

Started

Dec 2023

Expected to finish

Jan 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged 18-80 years old with rotator cuff tendinopathy * A PRP or CTM-type injection was determined by the clinician to be the proper medical treatment course and patient is willing to undergo the injection Exclusion Criteria: * Patients with adhesive capsulitis * Patients with acromio-clavicular joint impingement, retracted tears, significant labral lesions or significant glenohumeral arthrosis * Patients with joint instability * History of shoulder surgery or corticosteroid injection in the past 3 months * Patients with any medical conditions that affect healing, such as end-stage renal disease or uncontrolled diabetes

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Rotator cuff tendinitis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

disease of the tendon Rotator Cuff Injuries rotator cuff syndrome Shoulder Pain tendinitis tendinosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Rotator cuff tendinitis Rotator cuff tendinosis Shoulder pain Tendinopathy

Contacts and locations

Locations

  • AHN Wexford Health & Wellness Pavilion

    Wexford, Pennsylvania, 15090, United States

  • AHN Wexford Hospital

    Wexford, Pennsylvania, 15090, United States

  • Allegheny Health Network Allegheny General Hospital

    Pittsburgh, Pennsylvania, 15212, United States

  • Allegheny Health Network Federal North Medical Office Building

    Pittsburgh, Pennsylvania, 15212, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.